Ralf Kuriyel
Chief Tech/Sci/R&D Officer presso REPLIGEN CORPORATION
Patrimonio netto: 3 M $ in data 31/03/2024
Profilo
Attualmente, Ralf Kuriyel è vicepresidente senior di ricerca e sviluppo alla Repligen Corp. In passato è stato vicepresidente di ricerca e sviluppo per Pall Life Sciences e vicepresidente di ricerca e sviluppo delle applicazioni sul campo presso Pall Corp. Il sig. Kuriyel ha conseguito una laurea e una laurea presso il Rensselaer Polytechnic Institute.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
REPLIGEN CORPORATION
0.03% | 18/03/2024 | 17 719 ( 0.03% ) | 3 M $ | 31/03/2024 |
Posizioni attive di Ralf Kuriyel
| Società | Posizione | Inizio |
|---|---|---|
| REPLIGEN CORPORATION | Chief Tech/Sci/R&D Officer | 18/10/2016 |
Precedenti posizioni note di Ralf Kuriyel
| Società | Posizione | Fine |
|---|---|---|
| PALL CORPORATION | Corporate Officer/Principal | 01/10/2016 |
Cytiva US LLC
 Cytiva US LLC BiotechnologyHealth Technology Part of Danaher Corp., Cytiva US LLC is a private company that specializes in aerospace filtration technology. The company is based in Marlborough, MA. The company push the limits of what's possible to enable the next generation of air travel. | Chief Tech/Sci/R&D Officer | 01/10/2016 |
Formazione di Ralf Kuriyel
| Tufts University | Doctorate Degree |
| Rensselaer Polytechnic Institute | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| REPLIGEN CORPORATION | Health Technology |
| Aziende private | 2 |
|---|---|
Pall Corp.
 Pall Corp. Medical SpecialtiesHealth Technology Pall Corp. designs, manufactures, and markets filtration and separation equipment. Its products are used to remove solid, liquid, and gaseous contaminants from a variety of liquids and gases. The firm has Life Sciences and Industrial segments. The Life Sciences segment focuses on developing, manufacturing, and selling products to customers in the medical, biopharmaceuticals, and food and beverage markets. The Industrial segment focuses on developing, manufacturing and selling products to customers in the process technologies, aerospace, and microelectronics markets. The company was founded by David B. Pall on July 31, 1946 and is headquartered in Port Washington, NY. | Health Technology |
Cytiva US LLC
Cytiva US LLC BiotechnologyHealth Technology Part of Danaher Corp., Cytiva US LLC is a private company that specializes in aerospace filtration technology. The company is based in Marlborough, MA. The company push the limits of what's possible to enable the next generation of air travel. | Health Technology |
- Borsa valori
- Insiders
- Ralf Kuriyel
